On ECHEMI
Home > Drugs > Mirtazapine Registered Holders
Mirtazapine structure

Mirtazapine structure

Mirtazapine

Mirtazapine is a potent tetracyclic antidepressant.Target: 5-HT ReceptorMirtazapine, the novel antidepressant, has a dual mode of action. It is a noradrenergic and specific serotonergic antidepressant (NaSSA) that acts by antagonizing the adrenergic alpha2-autoreceptors and alpha2-heteroreceptors as well as by blocking 5-HT2 and 5-HT3 receptors [1].Mirtazapine appears to have a substantial ameliorating effect on hot flushes and perspiration bouts. It is postulated that the 5-HT(2A) block

Find 35 Related Holders

MAITHRI DRUGS PRIVATE LTD
United States United States

API Registration Country

API Active
APITORIA PHARMA PRIVATE LTD
United States United States

API Registration Country

API Active
TIANISH LABORATORIES PRIVATE LTD
United States United States

API Registration Country

API Active
Neuland Laboratories Limited.
Japan Japan

API Registration Country

API Active
KOLON LIFE SCIENCE,INC.
Japan Japan

API Registration Country

API Active
HETERO DRUGS LTD
United Kingdom United Kingdom

API Registration Country

API Active
  • Founded in:

    2011-10-24 00:00:00
  • Country:

    United Kingdom United Kingdom
  • Address:

    10b New Road, Chatham, Kent, England, ME4 4QR
Sumitomo Chemical Co.,Ltd
Japan Japan

API Registration Country

API Active
  • Country:

    Japan Japan
MEDICHEM SA
Spain Spain

API Registration Country

API Active
  • Country:

    Spain Spain
  • Address:

    FRUCTUOS GELABERT 6-8, BARCELONA, SANT JOAN DESPI
  • Email:

Aspen Oss B.V.
Netherlands Netherlands

API Registration Country

API Active
  • Country:

    Netherlands Netherlands
  • Address:

    Kloosterstraat 6, 5349AB Oss
  • Email:

TAPI NL B.V.
France France

API Registration Country

API Active
  • Founded in:

    2025-02-04 00:00:00
  • Country:

    France France
  • Address:

    55 Piet Heinkade 1019GM Amsterdam PAYS-BAS
  • Email:

Recommended Suppliers of Mirtazapine
View 102 Suppliers Request for Quotation
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.